Skip to main content
OpenTrials
Completed

NCT Number: NCT02027051

Etude génétique Des Arméniens

This study aims at better understanding the genetic structure of the Armenians, an old population whose genetics has not been the subject of many studies. We will study 500 individuals whom grandparents originate from different regions of Armenia. Each individual will be genotyped using a large panel of genetic markers. Principal component analysis will be used to analyze the genetic structure of this population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

50 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hovnanian

Paris, 75743, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Four grand-parents originating from Armenia

Exclusion criteria

  • One or more grand-parents not originating from Armenia

Treatment and study plan

Primary outcomes

  1. Genome wide genotyping of individuals

    Time frame: 3 months following inclusion

Secondary outcomes

  1. Principal component analysis of genotypes

    Time frame: Three months after completion of individual genotypes

Other outcomes

  1. Genetic structure

    Time frame: One month after principal component analysis of individuals

Sponsors and collaborators

Lead sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Other Gov

Registry information

Important dates

Study start
2014
Primary completion
2014
Study completion
2017
First posted
Jan 3, 2014
Registry last updated
Aug 30, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.